Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155892 · ClinicalTrials.gov registry record
Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 760
- Enrollment target
NCT04155892: Completed study, sponsored by Wake Forest University Health Sciences.
NCT04155892 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 760 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04155892 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 760 participants
- Enrollment target
Study Summary
The investigators are currently completing a data collection to try to optimize pediatric patients' preoperative screening, in the setting of an upper respiratory infection.
Primary Outcome
The 5 criteria (facial grimace, eye opening, conjugate gaze, purposeful movement, and tidal volume \> 5 cc/kg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2025-07-03 |
What the finished NCT04155892 record still lists
NCT04155892 is an observational study that tracks outcomes without assigning an intervention. The registered 760 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04155892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04155892 about?
NCT04155892 is a clinical study titled "Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)". The investigators are currently completing a data collection to try to optimize pediatric patients' preoperative screening, in the setting of an upper respiratory infection.
What is the current status of trial NCT04155892?
This trial is currently completed. The enrollment target is 760 participants. The study started on 2019-12-04. Estimated completion is 2025-07-03.
Who is sponsoring clinical trial NCT04155892?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI